|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_on1065930199 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
181107t20192019cau ob 001 0 eng |
| 010 |
|
|
|a 2018053771
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d OCLCO
|d N$T
|d YDX
|d N$T
|d OCLCF
|d YDX
|d UKAHL
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|d BRX
|d WAU
|d OCLCQ
|
| 019 |
|
|
|a 1100678014
|
| 020 |
|
|
|a 144086411X
|q electronic book
|
| 020 |
|
|
|a 9781440864117
|q electronic book
|
| 020 |
|
|
|z 9781440864100
|q hardcover
|q alkaline paper
|
| 029 |
1 |
|
|a AU@
|b 000065230547
|
| 029 |
1 |
|
|a AU@
|b 000067959267
|
| 035 |
|
|
|a (OCoLC)1065930199
|z (OCoLC)1100678014
|
| 042 |
|
|
|a pcc
|
| 050 |
1 |
4 |
|a RC483
|b .A38 2019
|
| 060 |
1 |
0 |
|a WM 402
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.89/18
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in psychedelic medicine :
|b state-of-the-art therapeutic applications /
|c Michael Winkelman and Ben Sessa, editors.
|
| 264 |
|
1 |
|a Santa Barbara :
|b Praeger, an imprint of ABC-CLIO, LLC,
|c [2019]
|
| 264 |
|
4 |
|c ©2019
|
| 300 |
|
|
|a 1 online resource (vii, 386 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Introduction : the psychedelic renaissance continues / Michael Winkelman and Ben Sessa -- Psychedelics and psychiatry : a new treatment model for the 21st century / Charlie Grob and Gary Bravo -- Therapeutic applications of 3,4-methyldioxmethamphetamine (MDMA) / Ben Sessa -- Psilocybin therapy for major depressive disorder / James Rucker -- Ketamine therapy for treatment resistant depression / L. Alison McInnes and Marc Ettensohn -- Evidence for the therapeutic effects of ayahuasca / Draulio Barros de Araujo -- Psilocybin for the treatment of substance use disorders / Ishani Rao and Greg Lydall -- Potential applications of cannabis and cannabinoids in the treatment of substance use disorder and in harm reduction / Jose Carlos Bouso, Rafael G. dos Santos and Jaime Hallak -- Psychedelic therapy as a complementary treatment approach for alcohol use disorders / Peter Eischens and William Leigh Atherton -- Effects of psychedelics on inflammation and immunity / Attila Szabo -- The protective role of dimethyltryptamine against ischemia-reperfusion injury / Ede Frecska, Attila Kovacs, and Attila Szabo -- Psychedelic treatment of disruptive personality patterns / Petr Winkler and Rita Kocárová -- Guidelines in applying psychedelic therapies / Friederike Meckel -- Training psychedelic therapists / Janis Phelps -- Community-based full-spectrum harm reduction approaches when caring for psychoactive and psychedelic related problems in a transformational festival / Maria Carmo Carvalho, Cristiana V. Pires, Ana Luísa Costa, Daniel Martins, Helena Valente, Ines Macedo, Paula Frango and Raquel Lira -- Microdosing psychedelics / James Fadiman and Sophia Korb -- Bringing psychedelics and entactogens into mainstream pharmaceuticals : a focus on MDMA / Anne C. Wagner, Michael C. Mithoefer, and Rick Doblin.
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on April 05, 2019).
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Mental illness.
|
| 650 |
|
0 |
|a Mental illness
|x Treatment.
|
| 650 |
|
0 |
|a Hallucinogenic drugs.
|
| 650 |
1 |
2 |
|a Mental Disorders
|x drug therapy
|
| 650 |
2 |
2 |
|a Hallucinogens
|
| 650 |
2 |
2 |
|a Hallucinogens
|x therapeutic use
|
| 650 |
|
2 |
|a Mental Disorders
|
| 650 |
|
2 |
|a Mental Disorders
|x therapy
|
| 650 |
|
6 |
|a Maladies mentales.
|
| 650 |
|
6 |
|a Maladies mentales
|x Traitement.
|
| 650 |
|
6 |
|a Hallucinogènes.
|
| 650 |
|
7 |
|a mental disorders.
|2 aat
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Hallucinogenic drugs.
|2 fast
|0 (OCoLC)fst00950651
|
| 650 |
|
7 |
|a Mental illness.
|2 fast
|0 (OCoLC)fst01016547
|
| 650 |
|
7 |
|a Mental illness
|x Treatment.
|2 fast
|0 (OCoLC)fst01016606
|
| 700 |
1 |
|
|a Winkelman, Michael,
|e editor.
|
| 700 |
1 |
|
|a Sessa, Ben,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in psychedelic medicine
|d Santa Barbara : Praeger, an imprint of ABC-CLIO, LLC, [2019]
|z 9781440864100
|w (DLC) 2018053052
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2031907
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 20345029
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16066580
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2031907
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH35450692
|
| 994 |
|
|
|a 92
|b IZTAP
|
